Molecular & Nucleic Acid Testing Market Reports

Molecular diagnostics include clinical tests with nucleic acid analytes or targets and represent some of the fastest growing and most dynamic clinical diagnostics markets. Exceeding $6 billion in global market volume, clinical molecular diagnostics are the leading application of nucleic acid tests. Kalorama Information offers specialized research in related markets of molecular point-of-care (POC) diagnostics, next-generation sequencing (NGS), molecular infectious disease diagnostics, and cancer diagnostics. Included in this section is information on the latest in molecular screening that catches infectious diseases such as HIV and Influenza, offering developments in the market soon to be used in molecular diagnostic treatments. Find the most up to date information on devices already on the market or still in development that will quickly determine appropriate treatment methods for patients, and understand the paradigm shift from curative medicine to predictive, personalized, and preemptive patient treatment. 

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: Jun 22, 2017 | Price: $3,500.00
The PCR testing market, which includes other NAAT technologies, is a large and diverse market.  This market consists of three segments:  the life science (research) NAAT market, the clinical NAAT market, and an "other" segment that includes forensics, environmental monitoring, veterinary, and other...
Published: May 26, 2017 | Price: $3,995.00
Lab Robotics Market  analyzes the current and potential world revenues for diagnostic laboratory robotic systems. The report's revenue data provide multiple year forecasts for different product segments and revenue forecasts focus on segments where robotics plays an important role, including the...
Published: Apr 12, 2017 | Price: $3,995.00
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes...
Published: Jan 30, 2017 | Price: $4,995.00
World Molecular Diagnostics MarketThis Kalorama Information report, The World Molecular Diagnostics Market, examines the current state for molecular assays, including cancer tests, NAT blood screening, transplantation testing, histology testing and inherited disease testing. Market size and...
Published: Feb 26, 2016 | Price: $4,200.00
Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health...
Published: Sep 30, 2015 | Price: $1,999.00
Molecular tests are used in just about every facet of laboratory medicine: infectious diseases, inherited diseases, coagulation, transplant medicine, prenatal and postnatal screening and cancer.  In The World Market for Molecular Diagnostics, 6th Edition, Kalorama IVD market analyst Shara Rosen,...
Published: Aug 15, 2014 | Price: $3,995.00
Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests)Physician office laboratories are a diverse but significant market for IVD products. The...
Published: Aug 13, 2014 | Price: $1,995.00
The in vitro diagnostics  (IVD) market attracts considerable interest.  There are hundreds of participating companies, competing in multiple areas of testing.  Each IVD segment could be said to function as an industry in and of itself.  There are companies who specialize in one area and companies...
Published: Feb 1, 2010 | Price: $2,500.00
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)Clinical laboratories are an essential part of the health industry. Kalorama Information estimates that approximately 80% of physicians' diagnoses are a result of laboratory tests.he constant...
Published: May 1, 2009 | Price: $250.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama...
Published: Apr 1, 2009 | Price: $1,500.00
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis...
Published: Jan 1, 2009 | Price: $3,995.00
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine. From Emerging to Emergent Technology Instrumentation now...
Published: Aug 1, 2008 | Price: $2,995.00
A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies and quantifies in greater detail some of the important areas that will have a transforming impact...
Published: Jun 1, 2008 | Price: $2,995.00
This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of...
Published: Jun 1, 2007 | Price: $1,990.00
Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.